BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 19808910)

  • 1. Chronically elevated plasma C-type natriuretic peptide level stimulates skeletal growth in transgenic mice.
    Kake T; Kitamura H; Adachi Y; Yoshioka T; Watanabe T; Matsushita H; Fujii T; Kondo E; Tachibe T; Kawase Y; Jishage K; Yasoda A; Mukoyama M; Nakao K
    Am J Physiol Endocrinol Metab; 2009 Dec; 297(6):E1339-48. PubMed ID: 19808910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating C-type natriuretic peptide (CNP) rescues chondrodysplastic CNP knockout mice from their impaired skeletal growth and early death.
    Fujii T; Komatsu Y; Yasoda A; Kondo E; Yoshioka T; Nambu T; Kanamoto N; Miura M; Tamura N; Arai H; Mukoyama M; Nakao K
    Endocrinology; 2010 Sep; 151(9):4381-8. PubMed ID: 20610569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diverging vasorelaxing effects of C-type natriuretic peptide in renal resistance arteries and aortas of GC-A-deficient mice.
    Steinmetz M; Potthast R; Sabrane K; Kuhn M
    Regul Pept; 2004 Jun; 119(1-2):31-7. PubMed ID: 15093694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Genetic basis for skeletal disease. CNP therapy for achondroplasia].
    Yasoda A; Nakao K
    Clin Calcium; 2010 Aug; 20(8):1212-8. PubMed ID: 20675932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-type natriuretic peptide/guanylate cyclase B system in ATDC5 cells, a chondrogenic cell line.
    Suda M; Tanaka K; Yasoda A; Komatsu Y; Chusho H; Miura M; Tamura N; Ogawa Y; Nakao K
    J Bone Miner Metab; 2002; 20(3):136-41. PubMed ID: 11984695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coexistence of C-type natriuretic peptide and atrial natriuretic peptide systems in the bovine cornea.
    Kim SZ; Kim HS; Lee KS; Lee SJ; Seul KH; Koh GY; Cho KW; Kim SH
    Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2671-7. PubMed ID: 10937581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dwarfism and early death in mice lacking C-type natriuretic peptide.
    Chusho H; Tamura N; Ogawa Y; Yasoda A; Suda M; Miyazawa T; Nakamura K; Nakao K; Kurihara T; Komatsu Y; Itoh H; Tanaka K; Saito Y; Katsuki M; Nakao K
    Proc Natl Acad Sci U S A; 2001 Mar; 98(7):4016-21. PubMed ID: 11259675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway.
    Yasoda A; Komatsu Y; Chusho H; Miyazawa T; Ozasa A; Miura M; Kurihara T; Rogi T; Tanaka S; Suda M; Tamura N; Ogawa Y; Nakao K
    Nat Med; 2004 Jan; 10(1):80-6. PubMed ID: 14702637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hormones and osteoporosis update. Effects of natriuretic peptides on endochondral bone growth].
    Yasoda A; Nakao K
    Clin Calcium; 2009 Jul; 19(7):1003-8. PubMed ID: 19567998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac and intestinal natriuretic peptides: insights from genetically modified mice.
    Kuhn M
    Peptides; 2005 Jun; 26(6):1078-85. PubMed ID: 15911075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natriuretic peptide system in the human retina.
    Rollín R; Mediero A; Roldán-Pallarés M; Fernández-Cruz A; Fernández-Durango R
    Mol Vis; 2004 Jan; 10():15-22. PubMed ID: 14737067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro effects of homologous natriuretic peptides on growth hormone and prolactin release in the tilapia, Oreochromis mossambicus.
    Fox BK; Naka T; Inoue K; Takei Y; Hirano T; Grau EG
    Gen Comp Endocrinol; 2007 Jan; 150(2):270-7. PubMed ID: 17107675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular physiology of natriuretic peptide signalling.
    Kuhn M
    Basic Res Cardiol; 2004 Mar; 99(2):76-82. PubMed ID: 14963665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart specific up-regulation of genes for B-type and C-type natriuretic peptide receptors in diabetic mice.
    Christoffersen C; Bartels ED; Nielsen LB
    Eur J Clin Invest; 2006 Feb; 36(2):69-75. PubMed ID: 16436087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skeletal contributions to plasma CNP forms: evidence from regional sampling in growing lambs.
    Prickett TC; Charles CJ; Yandle TG; Richards AM; Espiner EA
    Peptides; 2009 Dec; 30(12):2343-7. PubMed ID: 19664666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-type natriuretic peptide increases myocardial contractility and sinus rate mediated by guanylyl cyclase-linked natriuretic peptide receptors in isolated, blood-perfused dog heart preparations.
    Hirose M; Furukawa Y; Kurogouchi F; Nakajima K; Miyashita Y; Chiba S
    J Pharmacol Exp Ther; 1998 Jul; 286(1):70-6. PubMed ID: 9655843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical roles of the guanylyl cyclase B receptor in endochondral ossification and development of female reproductive organs.
    Tamura N; Doolittle LK; Hammer RE; Shelton JM; Richardson JA; Garbers DL
    Proc Natl Acad Sci U S A; 2004 Dec; 101(49):17300-5. PubMed ID: 15572448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic GMP-dependent protein kinase II plays a critical role in C-type natriuretic peptide-mediated endochondral ossification.
    Miyazawa T; Ogawa Y; Chusho H; Yasoda A; Tamura N; Komatsu Y; Pfeifer A; Hofmann F; Nakao K
    Endocrinology; 2002 Sep; 143(9):3604-10. PubMed ID: 12193576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of C-type natriuretic peptide expression.
    Sellitti DF; Koles N; Mendonça MC
    Peptides; 2011 Sep; 32(9):1964-71. PubMed ID: 21816187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy.
    Kishimoto I; Rossi K; Garbers DL
    Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2703-6. PubMed ID: 11226303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.